Leading medical organizations team up to bring new TB treatments to those in need
03/19/2015. International organizations Partners In Health (PIH), Médecins Sans Frontières (MSF), Interactive Research and Development (IRD) and their financial partner UNITAID will start in April the endTB project, a partnership aimed at radically changing the management of multidrug-resistant tuberculosis (MDR-TB).
By 2019, endTB will provide access to two new anti-TB drugs (bedaquiline and delamanid), for 2,600 MDR-TB patients in 16 countries. These are the first new anti-TB drugs developed in over 50 years and these drugs offer new hope to patients suffering from MDR-TB.
Read the article on MSF website
Related Articles
The futur of aid : INGOs in 2030
10/01/2017. It is both a challenge for traditional actors and an opportunity for humanitarian leaders to create a more inclusive and effective humanitarian ecosystem.
Famine looms in four countries as aid system struggles to cope, experts warn
02/12/2017. Campaigners say tens of millions in urgent need in Yemen, South Sudan, Nigeria and Somalia are in hands of an overwhelmed, outdated humanitarian network.
Unity within Security Council vital to prevent mass atrocities – UN chief Guterres
04/18/2017. Briefing the Security Council, António Guterres today stressed the importance of unity in the 15-member body to effectively address human rights violations as well as to prevent mass atrocities.
